Skip to content
2000
Volume 22, Issue 4
  • ISSN: 2211-3525
  • E-ISSN: 2211-3533

Abstract

Background: During COVID-19 pandemic a major conflict facing the clinician where to prove cure of the patients. Aims: The idea of confirming curability is based on clinical evaluation of the symptoms, laboratory investigations, and specific IgM, IgG anti-SARS-CoV-2 antibodies. Materials and Methods: All patients had presented with clinical features of COVID-19 positive PCR attended private clinic doctors consultant in internal medicine and infectious diseases, they did investigations in Lagash land private medical laboratory in Baghdad investigated and screened for COVID-19 by S. ferritin, D-dimer, Complete blood picture and LDH. All were reevaluated in the first month of infection by clinical examination, retesting, and screening for COVID-19 IgM IgG later to prove cure or evidence of viral infection in PCR negative cases. Results: All patients are of different ages with maximum years affected from adulthood till the age of one hundred years. Male were 170(54.3%) patients and females were 143 (45.7%) total 313 patients (100%). Most are moderate socioeconomic status, with a significant number having comorbidities. Conclusion: SARS-COVID-19 IgM, IgG levels can be used to confirm a cure of the infection.

Loading

Article metrics loading...

/content/journals/aia/10.2174/0122113525284502240217161226
2024-08-01
2024-11-19
Loading full text...

Full text loading...

/content/journals/aia/10.2174/0122113525284502240217161226
Loading

  • Article Type:
    Research Article
Keyword(s): antibodies; COVID-19; IgG; IgM; PCR; SARS-CoV-2
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test